Results 141 to 150 of about 7,431 (174)

A DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccine Encoding Thrombospondin-Related Adhesion Protein but Not Circumsporozoite Protein Partially Protects Healthy Malaria-Naive Adults against Plasmodium falciparum Sporozoite Challenge

, 2006
Susanna Dunachie, Michael Walther, Judy Epstein, Sheila M. Keating, Tamara Berthoud, Laura Andrews, Rikke Fredslund Andersen, Philip Bejon, Nilu Goonetilleke, Ian Poulton, D. P. Webster, G.A. Butcher, Katherine R. Watkins, Robert E. Sinden, Gail L. Levine, Thomas L. Richie, J Schneider, David C. Kaslow, Sarah C. Gilbert, Daniel J. Carucci, Adrian V. S. Hill   +20 more
openalex   +1 more source

Different Patterns of Immune Responses but Similar Control of a Simian-Human Immunodeficiency Virus 89.6P Mucosal Challenge by Modified Vaccinia Virus Ankara (MVA) and DNA/MVA Vaccines

, 2002
Rama Rao Amara, François Villinger, Silvija I. Staprans, John D. Altman, David C. Montefiori, Natalia Kozyr, Yan Xu, Linda S. Wyatt, Patricia L. Earl, James G. Herndon, Harold M. McClure, Bernard Moss, Harriet L. Robinson   +12 more
openalex   +1 more source

Different patterns of expansion, contraction and memory differentiation of HIV-1 Gag-specific CD8 T cells elicited by adenovirus type 5 and modified vaccinia Ankara vaccines

, 2011
Vinod Kumar Bhaskara Pillai, Sunil Kannanganat, Pablo Penaloza‐MacMaster, Lakshmi Chennareddi, Harriet L. Robinson, Jerry L. Blackwell, Rama Rao Amara   +6 more
openalex   +2 more sources

A multivalent RSV vaccine based on the Modified Vaccinia Ankara vector shows moderate protection against disease caused by RSV in older adults in a Phase 3 clinical study [PDF]

Elke Jordan, Victoria A. Jenkins, Günter Silbernagl, Maria Paulina Velasco Chávez, Darja Schmidt, Frauke Schnorfeil, Stephanie A. Schultz, Liddy Chen, Fernanda Salgado, Jeanne‐Marie Jacquet, Tobias Welte, Laurence De Moerlooze   +11 more
openalex   +1 more source

Effectiveness of modified vaccinia Ankara-Bavarian Nordic vaccine against mpox infection: emulation of a target trial.

BMJ
Navarro C, Lau C, Buchan SA, Burchell AN, Nasreen S, Friedman L, Okpokoro E, Austin PC, Tan DHS, Gubbay JB, Kwong JC, Mishra S, Canadian Immunization Research Network Provincial Collaborative Network Investigators.   +12 more
europepmc   +1 more source

Comparing Adjuvanted H28 and Modified Vaccinia Virus Ankara Expressing H28 in a Mouse and a Non-Human Primate Tuberculosis Model

, 2013
Rolf Billeskov, Jan Pravsgaard Christensen, Claus Aagaard, Peter Andersen, Jes Dietrich   +4 more
openalex   +2 more sources

Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study. [PDF]

EClinicalMedicine
Mazzotta V, Lepri AC, Matusali G, Cimini E, Piselli P, Aguglia C, Lanini S, Colavita F, Notari S, Oliva A, Meschi S, Casetti R, Mondillo V, Vergori A, Bettini A, Grassi G, Pinnetti C, Lapa D, Tartaglia E, Gallì P, Mondi A, Montagnari G, Gagliardini R, Nicastri E, Lichtner M, Sarmati L, Tamburrini E, Mastroianni C, Stingone C, Siddu A, Barca A, Fontana C, Agrati C, Girardi E, Vaia F, Maggi F, Antinori A, Mpox Vaccine Lazio Study Group.   +37 more
europepmc   +1 more source

Promoter and Leader Sequence Effects on Immunological Potency of Recombinant Modified Vaccinia Virus Ankara Delivering Tuberculosis Antigens

, 2016
Yper Hall
openalex   +1 more source

Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers. [PDF]

Pathogens, 2019
López-Camacho C, Kim YC, Abbink P, Larocca RA, Huiskonen JT, Barouch DH, Reyes-Sandoval A.   +6 more
europepmc   +1 more source

The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host

, 2018
Eva Calvo-Pinilla, Simon Gubbins, Peter Mertens, Javier Ortego, Javier Castillo‐Olivares   +4 more
openalex   +1 more source